Reports Library Publication
Insight Consumer Healthcare Asia-Pacific December / January 2026
27th January 2026 by CHC Insight
- Eye Care Dry eye education boosts category
- Sleep Aids New formats and products with additional benefits introduced
- Smoking Control Smoking rates down but vaping concerns persist
- Other Lifestyle CHC OTC sexual health category emerging in Japan
- News Review Hisamitsu set to go private in management buyout
- Innovation Round-up OTC Asverin approved in Japan, topical Tylenol released in China
Order this report
Why buy this report?
"The Market Reports in this issue demonstrate that Lifestyle CHC categories are among the most active in terms of regulatory updates and NPD, with marketers scrambling to meet health needs caused by stressful, modern lifestyles (e.g. to regulate sleep and mood) and self-care encouraged for sexual health and chronic conditions to help reduce government healthcare expenditure. Meanwhile, as we gallop towards the Year of the Horse, geopolitical tensions and economic uncertainty are ongoing, so cautious consumer spending is likely to continue to provide a challenge for CHC marketers."
Nicholas Hall